DK1781682T3 - B7-H5, et kostimulerende polypeptid - Google Patents

B7-H5, et kostimulerende polypeptid

Info

Publication number
DK1781682T3
DK1781682T3 DK05763338T DK05763338T DK1781682T3 DK 1781682 T3 DK1781682 T3 DK 1781682T3 DK 05763338 T DK05763338 T DK 05763338T DK 05763338 T DK05763338 T DK 05763338T DK 1781682 T3 DK1781682 T3 DK 1781682T3
Authority
DK
Denmark
Prior art keywords
costimulatory polypeptide
costimulatory
polypeptide
Prior art date
Application number
DK05763338T
Other languages
English (en)
Inventor
Lieping Chen
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of DK1781682T3 publication Critical patent/DK1781682T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
DK05763338T 2004-06-24 2005-06-24 B7-H5, et kostimulerende polypeptid DK1781682T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58249104P 2004-06-24 2004-06-24
PCT/US2005/022321 WO2006012232A1 (en) 2004-06-24 2005-06-24 B7-h5, a costimulatory polypeptide

Publications (1)

Publication Number Publication Date
DK1781682T3 true DK1781682T3 (da) 2013-06-03

Family

ID=35786526

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05763338T DK1781682T3 (da) 2004-06-24 2005-06-24 B7-H5, et kostimulerende polypeptid

Country Status (9)

Country Link
US (6) US7919585B2 (da)
EP (1) EP1781682B1 (da)
CA (1) CA2572239C (da)
DK (1) DK1781682T3 (da)
ES (1) ES2405273T3 (da)
PL (1) PL1781682T3 (da)
PT (1) PT1781682E (da)
SI (1) SI1781682T1 (da)
WO (1) WO2006012232A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1781682E (pt) 2004-06-24 2013-05-14 Mayo Foundation B7-h5, um polipéptido coestimulante
US8231872B2 (en) 2005-04-25 2012-07-31 The Trustees Of Dartmouth College Regulatory T cell mediator proteins and uses thereof
US8236304B2 (en) * 2005-04-25 2012-08-07 Trustees Of Dartmouth College Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity
WO2010027423A2 (en) 2008-08-25 2010-03-11 Amplimmune, Inc. Compositions of pd-1 antagonists and methods of use
EP2552947A4 (en) 2010-03-26 2013-11-13 Dartmouth College VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING ACTIVE SUBSTANCES AND USE THEREOF
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
AU2013277051B2 (en) * 2012-06-22 2018-06-07 King's College London Novel VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
AU2013312211B2 (en) 2012-09-07 2018-03-29 King's College London VISTA modulators for diagnosis and treatment of cancer
WO2014133728A2 (en) 2013-03-01 2014-09-04 Albert Einstein College Of Medicine Of Yeshiva University Hhla2 as a novel inhibitor of human immune system and uses thereof
JP6682426B2 (ja) * 2013-05-24 2020-04-15 メディミューン，エルエルシー 抗ｂ７−ｈ５抗体およびその使用
EP3003390B1 (en) * 2013-06-06 2021-07-07 Pierre Fabre Médicament Anti-c10orf54 antibodies and uses thereof
WO2015097536A2 (en) 2013-12-24 2015-07-02 Janssen Pharmaceutical Nv Anti-vista antibodies and fragments
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
AU2015274504B2 (en) 2014-06-11 2021-02-04 Kathy A. Green Use of VISTA agonists and antagonists to suppress or enhance humoral immunity
AU2015357463B2 (en) 2014-12-05 2021-10-07 Immunext, Inc. Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
US11582669B2 (en) 2015-02-05 2023-02-14 Apple Inc. Performing handover between short-range and cellular wireless networks
BR112017027870A2 (pt) 2015-06-24 2018-08-28 Janssen Pharmaceutica Nv anticorpos e fragmentos anti-vista
US10899836B2 (en) 2016-02-12 2021-01-26 Janssen Pharmaceutica Nv Method of identifying anti-VISTA antibodies
WO2017175058A1 (en) 2016-04-07 2017-10-12 Janssen Pharmaceutica Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
CA3020848A1 (en) 2016-04-15 2017-10-19 Janssen Pharmaceuticals, Inc. Anti-human vista antibodies and use thereof
KR102630011B1 (ko) 2017-01-11 2024-01-26 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
JP7211961B2 (ja) 2017-03-14 2023-01-24 ファイヴ プライム セラピューティクス インク 酸性ｐＨでＶＩＳＴＡに結合する抗体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837306A (en) * 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
WO2002008284A2 (en) 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US20030073129A1 (en) * 1998-09-01 2003-04-17 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6924355B2 (en) * 1998-09-01 2005-08-02 Genentech, Inc. PRO1343 polypeptides
US7026448B2 (en) 1998-09-01 2006-04-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5249700A (en) 1999-07-08 2001-01-30 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins
AU6531101A (en) 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1309620A2 (en) 2000-06-23 2003-05-14 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
CA2416456A1 (en) 2000-07-20 2002-01-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7265210B2 (en) * 2000-09-15 2007-09-04 Genentech, Inc. Anti-PRO9821 antibodies
CN1155615C (zh) 2000-10-31 2004-06-30 上海市肿瘤研究所 具有抑制癌细胞生长功能的新的人蛋白及其编码序列
WO2002057303A2 (en) 2001-01-12 2002-07-25 Hybrigenics Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides
EP2314676A1 (en) 2002-11-26 2011-04-27 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
PT1781682E (pt) 2004-06-24 2013-05-14 Mayo Foundation B7-h5, um polipéptido coestimulante
JP2008532516A (ja) 2005-03-11 2008-08-21 ジェネンテック・インコーポレーテッド 遺伝子破壊、組成物、およびそれに関連する方法
US7655778B2 (en) * 2006-02-28 2010-02-02 Curonix Co., Ltd. SISP-1, a novel p53 target gene and use thereof
KR20110074850A (ko) 2008-08-25 2011-07-04 앰플리뮨, 인크. Ｐｄ-１ 길항제 및 그의 사용 방법
CN101989109A (zh) 2009-07-29 2011-03-23 鸿富锦精密工业（深圳）有限公司 螺钉固定装置

Also Published As

Publication number Publication date
US10501520B2 (en) 2019-12-10
US20110245468A1 (en) 2011-10-06
US9012409B2 (en) 2015-04-21
US20130315905A1 (en) 2013-11-28
US7919585B2 (en) 2011-04-05
WO2006012232A1 (en) 2006-02-02
US20080248007A1 (en) 2008-10-09
EP1781682A1 (en) 2007-05-09
SI1781682T1 (sl) 2013-05-31
EP1781682B1 (en) 2013-03-13
US8426563B2 (en) 2013-04-23
CA2572239C (en) 2019-07-09
US20200239542A1 (en) 2020-07-30
PT1781682E (pt) 2013-05-14
EP1781682A4 (en) 2007-09-05
US20150203564A1 (en) 2015-07-23
US9884903B2 (en) 2018-02-06
ES2405273T3 (es) 2013-05-30
CA2572239A1 (en) 2006-02-02
US11760787B2 (en) 2023-09-19
PL1781682T3 (pl) 2013-08-30
US20180251515A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
DK1781682T3 (da) B7-H5, et kostimulerende polypeptid
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
NO20051522D0 (no) Kabelskjotbeskytter.
ITRM20050287A1 (it) Polsino per orologio.
DE502005007457D1 (de) Mikroemulsionen
NO20052746D0 (no) Avlopsenhet.
DE602005007364D1 (de) Peptidcyclisierung
NO20041374L (no) Bolgekraftverk.
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
NO20053363D0 (no) Malrettede enkle epitoper.
DE502005001451D1 (de) Fugenabdeckprofil
NO20052482D0 (no) Redningskokong.
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
NO20040762L (no) Stromskinne.
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
ES1058102Y (es) Lentilla terapeutica.
FR2879415B1 (fr) Epingle a chignon
NL1028622A1 (nl) Stelwig.
FR2871811B1 (fr) Endofucanase recombinante
SE0400275D0 (sv) New polypeptide
ITRM20040071A1 (it) Cravatta a chiusura lampo.
NL1025196A1 (nl) Hark-Zeef-Vork.
ES1058502Y (es) Respaldo plegable.
ITRM20020127U1 (it) Poltrona a conformazione ovoidale.